Abiopharma

ABCELLERA BIOLOGICS INC. (ABCL)

Symbol	ABCL
Name	ABCELLERA BIOLOGICS INC.
Sector	HEALTH CARE
Region	North America
Industry	Pharmaceuticals and Biotechnology
Address	2215 YUKON STREET, VANCOUVER, British Columbia, V5Y 0A1, Canada
Telephone	+1 604 559-9005
Fax	—
Email	—
Website	https://www.abcellera.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001703057
Description	AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The companys AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners. Additional info from NASDAQ: AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The companys AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

2026-09-02 20:05

Press Release: AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

2026-09-02 20:05

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

2026-08-24 21:21

Director Hayden Michael R 🟢 acquired 53.6K shares of AbCellera Biologics Inc. (ABCL) at $10.64 Transaction Date: Aug 24, 2026 | Filing ID: 058684

2026-08-18 18:45

Director Montalbano John S. 🟢 acquired 10.0K shares of AbCellera Biologics Inc. (ABCL) at $11.03 Transaction Date: Aug 18, 2026 | Filing ID: 000008

2026-08-14 16:04

Booth Andrew 🟢 acquired 37.2K shares of AbCellera Biologics Inc. (ABCL) at $10.32 Transaction Date: Aug 14, 2026 | Filing ID: 000008

2026-08-13 19:01

Director Hayden Michael R 🔴 sold 50.0K shares of AbCellera Biologics Inc. (ABCL) Transaction Date: Aug 11, 2026 | Filing ID: 056653

2026-08-13 04:05

Press Release: AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

2026-08-13 04:05

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

2026-08-11 20:01

Press Release: AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

2026-08-11 20:01

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Trial ID	Title	Phase	Indication	Status	Start Date	Completion Date	Source
NCT07108894	A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Part…	Phase1	Healthy Volunteers	Active_Not_Recruiting	2025-07-25	2027-04-01	ClinicalTrials.gov
NCT07118891	Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause	Phase1	Vasomotor Symptoms Associated With Menopause	Active_Not_Recruiting	2025-06-23	2027-02-01	ClinicalTrials.gov

Total clinical trials: 2

Product Name	Type	Development Stage	Therapeutic Area	Study Status	Trial ID
Placebo (Normal Saline 0.9%)	Other	Phase PHASE1	Healthy Volunteers	ACTIVE_NOT_RECRUITING	NCT07108894
ABCL575	Other	Phase PHASE1	Healthy Volunteers	ACTIVE_NOT_RECRUITING	NCT07108894
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	ACTIVE_NOT_RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	ACTIVE_NOT_RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo (Normal Saline 0.9%)	Other	Phase PHASE1	Healthy Volunteers	RECRUITING	NCT07108894
ABCL575	Other	Phase PHASE1	Healthy Volunteers	RECRUITING	NCT07108894
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	Other	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo	BIOLOGICAL	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
ABCL635	BIOLOGICAL	Phase PHASE1	Vasomotor Symptoms Associated With Menopause	RECRUITING	NCT07118891
Placebo (Normal Saline 0.9%)	BIOLOGICAL	Phase PHASE1	Healthy Volunteers	RECRUITING	NCT07108894
ABCL575	BIOLOGICAL	Phase PHASE1	Healthy Volunteers	RECRUITING	NCT07108894

Total products: 68